Piyush Goyal criticises firms attempts to secure pharma patents through minor innovations
New Delhi: Millions of people could be denied access to affordable medicines due to attempts by companies to secure pharmaceutical patents through minor innovations, Commerce and Industry Minister Piyush Goyal cautioned on Sunday, as he condemned such practices in the pharmaceutical industry.
Addressing an event, he emphasized that the pursuit of "super-natural" profits by a few companies and their shareholders comes at the cost of widespread access to quality and equitable healthcare.
According to PTI, Goyal said, "I received requests very often that we should also allow pharmaceutical companies... to have incremental changes to their patents and allow them to have a fresh patent for another long period of time, which we normally understand that as evergreening of patents.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.